71 related articles for article (PubMed ID: 16325274)
1. Tumor necrosis factor-alpha activates the extrapituitary PRL promoter in myeloid leukemic cells.
Gerlo S; Verdood P; Kooijman R
J Neuroimmunol; 2006 Mar; 172(1-2):206-10. PubMed ID: 16325274
[TBL] [Abstract][Full Text] [Related]
2. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
[TBL] [Abstract][Full Text] [Related]
3. The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP.
Reem GH; Ray DW; Davis JR
J Mol Endocrinol; 1999 Jun; 22(3):285-92. PubMed ID: 10343287
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta.
Jackson TA; Schweppe RE; Koterwas DM; Bradford AP
Mol Endocrinol; 2001 Sep; 15(9):1517-28. PubMed ID: 11518800
[TBL] [Abstract][Full Text] [Related]
5. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.
Gellersen B; Kempf R; Telgmann R; DiMattia GE
Mol Endocrinol; 1994 Mar; 8(3):356-73. PubMed ID: 8015553
[TBL] [Abstract][Full Text] [Related]
6. The role of protein kinase C signaling in activated DRA transcription.
Setterblad N; Onyango I; Pihlgren U; Rask L; Andersson G
J Immunol; 1998 Nov; 161(9):4819-24. PubMed ID: 9794414
[TBL] [Abstract][Full Text] [Related]
7. Pulses of prolactin promoter activity depend on a noncanonical E-box that can bind the circadian proteins CLOCK and BMAL1.
Leclerc GM; Boockfor FR
Endocrinology; 2005 Jun; 146(6):2782-90. PubMed ID: 15774559
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of interleukin-6 promoter by parathyroid hormone, tumor necrosis factor alpha, and interleukin-1beta in UMR-106 osteoblastic cells is inhibited by protein kinase C antagonists.
Nagy Z; Radeff J; Stern PH
J Bone Miner Res; 2001 Jul; 16(7):1220-7. PubMed ID: 11450697
[TBL] [Abstract][Full Text] [Related]
9. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer-binding protein alpha is a physiological regulator of prolactin gene expression.
Jacob KK; Stanley FM
Endocrinology; 1999 Oct; 140(10):4542-50. PubMed ID: 10499509
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C in pitavastatin-induced human paraoxonase I expression in Huh7 cells.
Arii K; Suehiro T; Ikeda Y; Kumon Y; Inoue M; Inada S; Takata H; Ishibashi A; Hashimoto K; Terada Y
Metabolism; 2010 Sep; 59(9):1287-93. PubMed ID: 20092859
[TBL] [Abstract][Full Text] [Related]
12. LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent.
Shames BD; Selzman CH; Pulido EJ; Meng X; Meldrum DR; McIntyre RC; Harken AH; Banerjee A
J Surg Res; 1999 May; 83(1):69-74. PubMed ID: 10210645
[TBL] [Abstract][Full Text] [Related]
13. Turkey prolactin gene regulation by VIP through 35-bp cis-acting element in the proximal promoter.
Kang SW; Gazzillo LC; You S; Wong EA; El Halawani ME
Gen Comp Endocrinol; 2004 Sep; 138(2):157-65. PubMed ID: 15302265
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
Castillo AI; Aranda A
Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
[TBL] [Abstract][Full Text] [Related]
15. Myeloid leukemic cells express and secrete bioactive pituitary-sized 23 kDa prolactin.
Kooijman R; Gerlo S; Coppens A; Hooghe-Peters EL
J Neuroimmunol; 2000 Oct; 110(1-2):252-8. PubMed ID: 11024557
[TBL] [Abstract][Full Text] [Related]
16. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
Hou Z; Srivastava S; Mistry MJ; Herbst MP; Bailey JP; Horseman ND
Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mitogen-activated protein kinase in cyclic adenosine 3',5'-monophosphate-induced hormone gene expression in rat pituitary GH(3) cells.
Yonehara T; Kanasaki H; Yamamoto H; Fukunaga K; Miyazaki K; Miyamoto E
Endocrinology; 2001 Jul; 142(7):2811-9. PubMed ID: 11416000
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin F2alpha amplifies tumor necrosis factor-alpha promoter activity by the FPB prostanoid receptor.
Fujino H; Regan JW
Biochem Biophys Res Commun; 2004 May; 317(4):1114-20. PubMed ID: 15094384
[TBL] [Abstract][Full Text] [Related]
19. Mediation by calcium of thyrotropin--releasing hormone action on the prolactin promoter via transcription factor pit-1.
Yan GZ; Bancroft C
Mol Endocrinol; 1991 Oct; 5(10):1488-97. PubMed ID: 1775132
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
Coleman DT; Chen X; Sassaroli M; Bancroft C
Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]